Human Immunodeficiency Virus Type 1 (HIV-1) antibody (Biotin)
-
- Target
- Human Immunodeficiency Virus Type 1 (HIV-1)
- Reactivity
- Human Immunodeficiency Virus (HIV)
-
Host
- Goat
-
Clonality
- Polyclonal
-
Conjugate
- Biotin
-
Application
- Western Blotting (WB), Enzyme Immunoassay (EIA)
- Immunogen
- Purified native p24 from strain IIIB
-
-
- Application Notes
-
Avidin and streptavidin amplification systems for ELISA and Western blot.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. - Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 4-5 mg/mL (OD280, E0.1% = 1.4)
- Buffer
- 0.01 M PBS, pH 7.2, containing 0.09 % sodium azide. No stabilizing proteins have been added
- Preservative
- Sodium azide
- Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handling Advice
- Avoid repeated freezing and thawing.
- Storage
- 4 °C/-20 °C
- Storage Comment
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
- Target
- Human Immunodeficiency Virus Type 1 (HIV-1)
- Alternative Name
- HIV-1
- Target Type
- Virus
- Background
- HIV is a highly variable virus which mutates very readily. This means there are many different strains of HIV, even within the body of a single infected person. The strains of HIV1 can be classified into three groups : the "major" group M, the "outlier" group O and the "new" group N. These three groups may represent three separate introductions of simian immunodeficiency virus into humans. Group O appears to be restricted to West-Central Africa and group N, discovered in 1998 in Cameroon, is extremely rare. More than 90 % of HIV1 infections belong to HIV1 group M.Synonyms: HIV-I, HIV1, Human immunodeficiency virus type 1
-